Blockchain Registration Transaction Record
VERAXA Biotech Completes Business Combination, Begins Trading on Nasdaq
VERAXA Biotech (VRXA) completes business combination with Voyager Acquisition Corp., begins trading on Nasdaq. Focus on BiTAC platform for cancer therapies.
This news matters because it signals the public market entry of a biotech firm with a promising platform for next-generation cancer therapies. The BiTAC platform's ability to selectively target cancer cells could lead to more effective and less toxic treatments, addressing a critical need in oncology. The substantial financing secured also indicates strong investor confidence, which may accelerate the development of these therapies toward clinical trials and eventual patient access.
| Blockchain | Details |
|---|---|
| Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
| Transaction ID | 0xc2278370f8c5ecf4cd5e5b9e5c6eac4cf6197c58592f1833f909453ac1ac01e3 |
| Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
| Chain | polygon-main |
| NewsRamp Digital Fingerprint | joltJ8YT-8dae2bcd6c626de811c9ca5cc562ca5b |